Expanded Access to ABBV-CLS-484

Calico Life Sciences

Status

Conditions: Advanced Solid Tumor Cancer

Treatments: Drug: DRUG: ABBV-CLS-484

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT06188975

C24-918

Details and patient eligibility

About

This is an expanded access program (EAP) for eligible participants. This program is designed to provide access to ABBV-CLS-484 prior to approval by the local regulatory agency. Availability will depend on territory eligibility. A medical doctor must decide whether the potential benefit outweighs the risk of receiving an investigational therapy based on the individual patient's medical history and program eligibility criteria.

Sex

Volunteers: No Healthy Volunteers

Inclusion criteria

Exclusion criteria